CD4 and psoriasis: Recently, a distinct subtypes of CD4+ T cell, Th17 cells, have emerged as a key player in psoriasis pathogenesis, which are more highly expressed in psoriatic dermis and make up more than 50%, even 90% of the CD4+ population in psoriatic lesions [7–9].